Medline Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
MDLN on Nasdaq
Location
Northfield, IL
Fiscal year end
31 December
Latest financial report
25 Feb 2026

Shareable Research Card

MDLN - Medline Inc. Financial Facts

MDLN - Medline Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q4 2025

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub

Return Loop

Why revisit this company facts page

Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.

Latest source-backed update
Latest metrics period Q4 2025
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
  • Current latest metrics period: Q4 2025.
  • Most recent SEC facts end date on this page: 31 Dec 2025.
  • Save this filer to return when the next filing-backed metric period changes the picture.

Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.

Create account to save this filer Open latest 10-Q/10-K hub

Latest update

Latest update for MDLN - Medline Inc.

New fact period available

Latest financial period: Q4 2025. Reopen this facts page to verify the newest reported period against the prior baseline.

Update date

25 Feb 2026

Page type

Company facts

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 25 Feb 2026.

Open recent updates hub Open latest 10-Q/10-K hub

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Create free account to save and revisit this page

Quick Takeaways

  • MDLN - Medline Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric summary will appear when SEC facts are available.

What Changed

  • No metrics are currently available for comparison on this facts page.
  • Changes will populate automatically as new 10-Q/10-K periods are processed.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

n/a

Insufficient Data Confidence low

Financial Health

Growth

Metric Latest value YoY change
Net Income (Loss) Attributable to Parent $7,000,000

Share Metrics

Metric Latest value YoY change
Entity Public Float $13,000,000,000
Weighted Average Number of Shares Outstanding, Basic 809,688,877
Weighted Average Number of Shares Outstanding, Diluted 809,688,877

Supporting Metrics

These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.

Metric Latest value YoY change
Accounts Payable, Current $961,000,000 +11%
Accounts Receivable, after Allowance for Credit Loss, Current $3,533,000,000 +9.8%
Accrued Liabilities, Current $1,452,000,000 -2.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $27,000,000 +145%
Additional Paid in Capital $10,717,000,000
Assets $38,484,000,000 +7%
Assets, Current $10,679,000,000 +29%
Cash and Cash Equivalents, at Carrying Value $1,939,000,000 +874%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,942,000,000 +677%
Deferred Income Tax Assets, Net $583,000,000
Deferred Tax Assets, Net of Valuation Allowance $747,000,000 +2568%
Deferred Tax Assets, Valuation Allowance $0 -100%
Earnings Per Share, Basic -0.01
Earnings Per Share, Diluted -0.01
Goodwill $8,079,000,000 +0.17%
Intangible Assets, Net (Excluding Goodwill) $13,893,000,000 -4.6%
Inventory, Net $4,769,000,000 +7%
Lessee, Operating Lease, Liability, to be Paid $591,000,000
Lessee, Operating Lease, Liability, to be Paid, Year Four $66,000,000
Lessee, Operating Lease, Liability, to be Paid, Year One $92,000,000
Lessee, Operating Lease, Liability, to be Paid, Year Three $77,000,000
Lessee, Operating Lease, Liability, to be Paid, Year Two $85,000,000
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $139,000,000
Liabilities $19,198,000,000 -1.3%
Liabilities and Equity $38,484,000,000 +7%
Liabilities, Current $2,490,000,000 +2%
Operating Lease, Liability $452,000,000 +12%
Operating Lease, Liability, Current $66,000,000 -13%
Operating Lease, Liability, Noncurrent $386,000,000 +17%
Operating Lease, Right-of-Use Asset $432,000,000 +12%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 -12%
Other Assets, Current $438,000,000 +10%
Other Assets, Noncurrent $23,027,000,000 -0.36%
Other Liabilities, Noncurrent $682,000,000 +14%
Preferred Stock, Par or Stated Value Per Share 0.0001
Preferred Stock, Shares Authorized 5,000,000,000
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Outstanding 0
Property, Plant and Equipment, Gross $5,939,000,000 +8.9%
Property, Plant and Equipment, Net $4,778,000,000 +4%
Retained Earnings (Accumulated Deficit) $7,000,000
Stockholders' Equity Attributable to Parent $10,737,000,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $19,286,000,000
Unrecognized Tax Benefits $0

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY